Khoday Group, Dabur Research Foundation launches 'ViraNorm' to fight Covid-19
The drug is add-on therapy for asymptomatic and symptomatic Covid patients. Khoday Group of Industries, a Bengaluru based company, has rolled out 'ViraNorm' - ayurvedic immuno-modulator, which helps treat Covid-19 patients. Through the launch of ‘ViraNorm’, Khoday Group is entering the alternative medicine sector. The drug ‘ViraNorm’ has been developed by Khoday Group in collaboration with Athera Dabur Research Foundation (DRF) LifeSciences. According to the company, ‘ViraNorm’ has undergone Phase 3 clinical trials in the country for an ayurvedic formulation and conducted accord...
Source: thehindubusinessline.com